BACKGROUND: Osteoarthritis of the trapeziometacarpal joint (TOA) or rizoarthrosis is a pathology particularly prevalent in post-menopausal women. It can be symptomatic, with associated pain, or asymptomatic, and in this latter case it is diagnosed by radiographical examination. TOA , when symptomatic, strongly affects quality of life. The treatment of TOA involves both pharmacological and non-pharmacological treatment (including local application of heat, ultrasound and splints). The major treatments, recommended by the European League Against Rheumatism consists of corticosteroids for pain control and hyaluronic acid (HA) for amelioration of functional capacity. The present study aimed at comparing the efficacy and tolerance of intra articular injections of two HA preparations, high-low molecular weight HA (HL) (Sinovial® HL; IBSA) and high molecular weight HA (HMW) (Sinovial® Mini, IBSA), in patients with TOA . METHODS: The observational and retrospective study involved overall 125 subjects, ageing from 45 to 85 years, who had clinical symptoms of TOA lasting at least 6 months. The patients received HL (66 subjects) or HMW (59 subjects) in two injections at baseline and after 15 days. The subjects were followed for 6 months, and the outcome measurements included pain control (through VA S scale) functional hand capacity, using the Duruoz Hand Index (DHI) and the change of the duration of morning stiffness, using the Italian version of the Health Assessment Questionnaire (HAQ). RESULTS: HL was found superior to HMW in all the three parameters examined, with a quicker and stronger pain relief, recovery of hand function as well as in self-assessment by the subjects. Both treatments were associated with very mod- est side effects. CONCLUSIONS: In conclusion, our data show the efficacy of HL and HMW for the treatment of TOA and the superior- ity of HL to HMW. Although these data are observational and retrospective, they pose the basis for future prospective studies focused on the use of HL and HMW in TOA .

Sallì, M., Sallì, S., Grasso, G., Sallì, L., Foti, C. (2021). Comparison of two hyaluronic acid preparations for the treatment of rizoarthrosis. GAZZETTA MEDICA ITALIANA. ARCHIVIO PER LE SCIENZE MEDICHE, 180(12), 860-866.

Comparison of two hyaluronic acid preparations for the treatment of rizoarthrosis

FOTI, Calogero
2021-01-01

Abstract

BACKGROUND: Osteoarthritis of the trapeziometacarpal joint (TOA) or rizoarthrosis is a pathology particularly prevalent in post-menopausal women. It can be symptomatic, with associated pain, or asymptomatic, and in this latter case it is diagnosed by radiographical examination. TOA , when symptomatic, strongly affects quality of life. The treatment of TOA involves both pharmacological and non-pharmacological treatment (including local application of heat, ultrasound and splints). The major treatments, recommended by the European League Against Rheumatism consists of corticosteroids for pain control and hyaluronic acid (HA) for amelioration of functional capacity. The present study aimed at comparing the efficacy and tolerance of intra articular injections of two HA preparations, high-low molecular weight HA (HL) (Sinovial® HL; IBSA) and high molecular weight HA (HMW) (Sinovial® Mini, IBSA), in patients with TOA . METHODS: The observational and retrospective study involved overall 125 subjects, ageing from 45 to 85 years, who had clinical symptoms of TOA lasting at least 6 months. The patients received HL (66 subjects) or HMW (59 subjects) in two injections at baseline and after 15 days. The subjects were followed for 6 months, and the outcome measurements included pain control (through VA S scale) functional hand capacity, using the Duruoz Hand Index (DHI) and the change of the duration of morning stiffness, using the Italian version of the Health Assessment Questionnaire (HAQ). RESULTS: HL was found superior to HMW in all the three parameters examined, with a quicker and stronger pain relief, recovery of hand function as well as in self-assessment by the subjects. Both treatments were associated with very mod- est side effects. CONCLUSIONS: In conclusion, our data show the efficacy of HL and HMW for the treatment of TOA and the superior- ity of HL to HMW. Although these data are observational and retrospective, they pose the basis for future prospective studies focused on the use of HL and HMW in TOA .
2021
Pubblicato
Rilevanza nazionale
Articolo
Sì, ma tipo non specificato
Settore MED/34 - MEDICINA FISICA E RIABILITATIVA
English
Con Impact Factor ISI
Sallì, M., Sallì, S., Grasso, G., Sallì, L., Foti, C. (2021). Comparison of two hyaluronic acid preparations for the treatment of rizoarthrosis. GAZZETTA MEDICA ITALIANA. ARCHIVIO PER LE SCIENZE MEDICHE, 180(12), 860-866.
Sallì, M; Sallì, S; Grasso, G; Sallì, L; Foti, C
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Comparison of two hyaluronic acid.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 444.07 kB
Formato Adobe PDF
444.07 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/290443
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact